Movement disorders in pregnancy

Neurologic Clinics

Volumn 22, Issue 4 SPEC. ISS., 2004, Pages 783-798

  Smith, Marsha S A ^a   Evatt, Marian L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIPARKINSON AGENT; AROMATIC LEVO AMINO ACID DECARBOXYLASE; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BUTYROPHENONE DERIVATIVE; CARBAMAZEPINE; CARBIDOPA; CLONAZEPAM; DECARBOXYLASE INHIBITOR; DEXTROPROPOXYPHENE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FOLIC ACID; GABAPENTIN; LEVODOPA; METHADONE; NEUROLEPTIC AGENT; OPIATE; OXYCODONE; PENICILLAMINE; PERGOLIDE; PHENOTHIAZINE; PRIMIDONE; PROPANOL; RESERPINE; ROPINIROLE; SULPIRIDE; TETRABENAZINE; UNINDEXED DRUG;

AGENESIS; ANTEVERTED NOSTRIL; ANTIPHOSPHOLIPID SYNDROME; APATHY; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CARDIOVASCULAR MALFORMATION; CHELATION THERAPY; CHOREA; CONNECTIVE TISSUE DISEASE; CUTIS LAXA; DEPRESSION; DRUG SAFETY; DYSTONIA; ESSENTIAL TREMOR; EXTRAPYRAMIDAL SYMPTOM; FETUS MALFORMATION; FINGER MALFORMATION; GILLES DE LA TOURETTE SYNDROME; GROWTH RETARDATION; HIRSUTISM; HUMAN; HUNTINGTON CHOREA; HYPERACTIVITY; HYPERTHERMIA; INFECTION; INGUINAL HERNIA; INTRAUTERINE GROWTH RETARDATION; IRON DEFICIENCY ANEMIA; IRRITABILITY; LOW BIRTH WEIGHT; LOW SET EAR; MENTAL DISEASE; MICROGNATHIA; MOOD DISORDER; MOTOR DYSFUNCTION; MYOGLOBINURIA; NAIL HYPOPLASIA; NEURAL TUBE DEFECT; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PERSONALITY DISORDER; POLYNEUROPATHY; PREGNANCY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; RESTLESSNESS; REVIEW; RHABDOMYOLYSIS; RHEUMATIC FEVER; SEIZURE; SHORT NOSE; SIDE EFFECT; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TERATOGENICITY; UREMIA; VERTEBRA MALFORMATION; VISUAL DISORDER; VITAMIN SUPPLEMENTATION; WILSON DISEASE;

EID: 4944244821     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2004.06.005     Document Type: Review

References (92)

1. K.A. Ekbom Restless legs syndrome Neurology 10 1960 868 873
2. S. Chokroverty Sleep disorders Bradley W.G. Daroff R.B. Fenechel G.M. Jankovic J. Neurology in cinical practice 3rd edition 2000 Butterworth-Heinemann Woburn (MA) 1781 1827
3. K.A. Lee, M.E. Zafke, and K. Baratte-Beebe Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron J Womens Health Gend Based Med 10 2001 335 341
4. A.E. Lang Akathisia and the restless legs syndrome Jankovic J. Tolosa E. Parkinson's disease and movement disorders 1993 Williams & Wilkins Baltimore 399 418
5. R.P. Allen, and C.J. Earley Restless legs syndrome: a review of clinical and pathophysiologic features J Clin Neurophysiol 18 2001 128 147
6. P.K. Sahota, S.S. Jain, and R. Dhand Sleep disorders in pregnancy Curr Opin Pulm Med 9 2003 477 483
7. S.T. O'Keeffe, K. Gavin, and J.N. Lavan Iron status and restless legs syndrome in the elderly Age Ageing 23 1994 200 203
8. J.W. Winkelman, G.M. Chertow, and J.M. Lazarus Restless legs sydndrome in end-stage renal disease Am J Kidney Dis 28 1996 372 378
9. S. Iannaccone, M. Zucconi, P. Marchettini, L. Ferini-Strambi, R. Nemni, and A. Quattrini Evidence of peripheral axonal neuropathy in primary restless legs syndrome Mov Disord 10 1995 2 9
10. C.J. Earley Restless legs syndrome N Engl J Med 348 2003 2103 2109
11. W. Hening, R. Allen, C. Earley, C. Kushida, D. Picchietti, and M. Silber The treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine review Sleep 22 1999 970 999
12. A.L. Chesson Jr., M. Wise, D. Davila, S. Johnson, M. Littner, and W.M. Anderson Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine report Sleep 22 1999 961 968
13. J. Buelke-Sam, R.A. Byrd, J.A. Johnson, J.P. Tizzano, and N.V. Owen Developmental toxicity of the dopamine agonist pergolide mesylate in CD-1 mice. Gestational exposure Neurotoxicol Teratol 13 1991 297 306
14. J. Buelke-Sam, R.A. Byrd, J.A. Johnson, J.P. Tizzano, and N.V. Owen Developmental toxicity of the dopamine agonist pergolide mesylate in CD-1 mice. II. Perinatal and postnatal exposure Neurotoxicol Teratol 13 1991 297 306
15. Requip (ropinirole). [product information] 1996 SmithKline Beecham Brentford, Middlesex (UK)
16. P. Hagell, P. Odin, and E. Vinge Pregnancy in Parkinson's disease: a review of the literature and a case report Mov Disord 13 1998 34 38
17. R.E. Staples, and P.A. Mattis Teratology of L-dopa Tetratology 8 1973 238
18. M.I. Botez, and B. Lambert Folate deficiency and restless legs syndrome in pregnancy N Engl J Med 297 1977 670
19. P. Wilson, and A.A. Preece Chorea gravidarum Arch Intern Med 49 1932 471 533
20. F. Cardoso Infectious and transmissible movement disorders Jankovic J. Tolosa E. Parkinson's disease and movement disorders 3rd edition 1997 Williams & Wilkins Baltimore 945 965
21. R.E. Wolf, and J.G. McBeath Chorea gravidarum in systemic lupus erythematosus J Rheumatol 12 1985 992 993
22. F. Cardoso Chorea gravidarum Arch Neurol 59 2002 868 870
23. J.O. Donaldson Neurologic emergencies in pregnancy Obstet Gynecol Clin North Am 18 1991 199 212
24. K. Ichikawa, R.C. Kim, H. Givelber, and G.H. Collins Chorea gravidarum. Report of a fatal case with neuropathological observations Arch Neurol 37 1980 429 432
25. J.F. Patterson Treatment of chorea gravidarum with haloperidol South Med J 72 1979 1220 1221
26. L.I. Golbe Pregnancy and movement disorders Neurol Clin 12 1994 497 508
27. G.G. Briggs, R.K. Freeman, and S.J. Yaffe Drugs in pregnancy and lactation 4th edition 1994 Williams & Wilkins Baltimore
28. L.J. Miller Clinical strategies for the use of psychotropic drugs during pregnancy Psychiatr Med 9 1991 275 298
29. H.L. Goldberg, and R. Nissim Psychotropic drugs in pregnancy and lactation Int J Psychiatry Med 24 1994 129 147
30. L.L. Altshuler, and M.P. Szuba Course of psychiatric disorders in pregnancy: dilemmas in pharmacologic management Neurol Clin 12 1994 613 635
31. L.J. Miller Psychiatric medication during pregnancy: understanding and minimizing risks Psychiatr Ann 24 1994 69 75
32. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes Cell 72 1993 971 983
33. G. Lesca, C. Goizet, and A. Durr Predictive testing in the context of pregnancy: experience in Huntington's disease and autosomal dominant cerebellar ataxia J Med Genet 39 2002 522 525
34. J.F. Gusella, N.S. Wexler, P.M. Conneally, S.L. Naylor, M.A. Anderson, and R.E. Tanzi A polymorphic DNA marker genetically linked to Huntington's disease Nature 306 1983 234 238
35. S. Hersch, R. Jones, W. Koroshetz, and K. Quaid The neurogenetics genie: testing for the Huntington's disease mutation Neurology 8 1994 1369 1373
36. N. Quinn, and A. Schrag Huntington's disease and other choreas J Neurol 245 1998 709 716
37. C. Craufurd, J.C. Thompson, and J.S. Snowden Behavioral changes in Huntington disease Neuropsychiatry Neuropsychol Behav Neurol 14 2001 219 226
38. American Academy of Pediatrics Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn Pediatrics 105 2000 880 887
39. P.M. McKeigue, and M.G. Marmot Stern G. Epidemology of Parkinson's disease 1990 Chapman and Hall London 295 306
40. S.K. Van Den Eeden, C.M. Tanner, A.L. Bernstein, R.D. Fross, A. Leimpeter, and D.A. Bloch Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity Am J Epidemiol 157 2003 1015 1022
41. H. Sawada, M. Ibi, T. Kihara, K. Honda, T. Nakamizo, and R. Kanki Estradiol protects dopaminergic neurons in a MPP + Parkinson's disease model Neuropharmacology 42 2002 1056 1064
42. S. Tao, H. Shu-Leong, and D. Ramaden Estrogen can down-regulate the human catechol-O-methlytransferase gene expression: its implication in Parkinson's disease Mov Disord 13 Suppl 2 1998 114
43. J. Fishman Biological action of cathecholoestrogens J Endocrinol 89 1981 59P
44. M. Periquet, M. Latouche, E. Lohman, N. Rawal, G. De Michele, and S. Ricard French Parkinson's Disease Genetics Study Group; The European Consortium on the Genetic Susceptibility in Parkinson's Disease. Parkin mutations are frequent in patients with early-onset Parkinsonism Brain 126 2003 1271 1278
45. C.B. Lücking, A. Durr, V. Bonifati, J. Vaughan, G. Michele, and T. Gasser Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's disease Genetics Study Group N Engl J Med 342 2000 1560 1567
46. C.A. Merchant, G. Cohen, C. Mytilineou, A. DiRocco, D. Moros, and S. Molinari Human transplacental transfer of carbidopa/levodopa J Neural Transm Park Dis Dement Sect 9 1995 239 242
47. Sinemet (levodopa + carbidopa) [product information] 1996 Merck, Sharp and Dohme Sollentuna (Sweden)
48. Madopark (levodopa + benserazide) [product information] 1996 Roche Skar-holmen (Sweden)
49. S. Kacew Adverse effects of drugs and chemicals in breast milk on the nursing infant J Clin Pharmacol 33 1993 213 221
50. J. Benito-Leon, and F. Bermejo Pregnancy in Parkinson's disease: a review of the literature and a case report Mov Disord 14 1999 194
51. A. Kupsch, and W.H. Oertel Selegiline, pregnancy and Parkinson's disease Mov Disord 13 1998 175 176
52. P.M. Whitaker-Azmita, X. Zhang, and C. Clarke Effects of gestational exposure to monamineoxidase inhibitors in rats:preliminary behavioral and neurochemical studies Neuropsychopharmacology 11 1994 125 132
53. Eldepryl (selegiline) [product information] 1996 Somerset Pharmacetuical Tampa (FL)
54. J.J. Nora, A.H. Nora, and G.L. Way Cardiovascular maldevelopment associated with maternal exposure to amantadine Lancet 2 1975 607
55. A. Berardelli, J.C. Rothwell, M. Hallett, P.D. Thompson, M. Manfredi, and C.D. Marsden The pathophysiology of primary dystonia Brain 121 1998 1195 1212
56. M. Hallett The neurophysiology of dystonia Arch Neurol 55 1998 601 603
57. R.L. Watts, and W.C. Koller Movement disorders: neurologic principles and practice 1996 McGraw-Hill
58. S.B. Bressman, D. de Leon, M.F. Brin, N. Risch, H. Shale, and R.E. Burke Idiopathic torsion dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance Ann Neurol 26 1989 612 620
59. J.D. Rogers, and S. Fahn Movement disorders and pregnancy Devinsky O. Feldman E. Hainline B. Neurological complications of pregnancy. Advances in neurology vol. 64 1994 Raven Press New York 163 178
60. Nomoto M, Kaseda S, Iwata S, Osame M, Fukuda T. Levodopa in pregnancy. Mov Disord;12:261.
61. M.C. Ball, and H.J. Sagar Levodopa in pregnancy Mov Disord 10 1995 115
62. Myobloc (botulinum toxin type B) [product information]. South San Francisco (CA): Elan Pharmaceuticals.
63. Botox (Botulinum toxin type A) [product information]. Irvine (CA): Allergan.
64. L. Robin, D. Herman, and R. Redett Botulism in a pregnant woman N Engl J Med 335 1996 823 824
65. J.M. Polo, J. Martin, and J. Berciano Botulism and pregnancy Lancet 348 1996 195
66. R.D. Bruun, and C.L. Budman The natural history of Tourette syndrome Adv Neurol 58 1992 1 6
67. M.M. Robertson The Gilles de la Tourette syndrome: the current status Br J Psychiatry 154 1989 147 169
68. A.K. Shapiro, and E. Shapiro Tourette syndrome: clinical aspects, treatment, and etiology Semin Neurol 2 1982 373 385
69. T.M. Hyde, and D.R. Weinberger Tourette's syndrome: a model neuropyschiatric disorder JAMA 273 1995 498 501
70. The Tourette's Syndrome Study Group Treatment of ADHD in children with tics: a randomized controlled trial Neurology 58 2002 527 536
71. J.G. Auerbach, S.L. Hans, J. Marcus, and S. Maeir Maternal psychotropic medication and neonatal behavior Neurotoxicol Teratol 14 1992 399 406
72. M. Frydman, B. Bonne-Tamir, L.A. Farrer, P.M. Conneally, K.A. Magazani, and S. Ashbel Assignment of the gene for Wilson disease to chromosome 13 Proc Natl Acad Sci USA 82 1985 1819 1821
73. P.C. Bull, G.R. Thomas, J.M. Rommens, J.R. Forbes, and D.W. Cox The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes's gene [erratum] Nat Genet 5 1993 327 337
74. B. Bonne-Tamir, M. Frydman, M.S. Agger, R. Bekeer, A.M. Bowcock, and J.M. Hebert Wilson's disease in Israel: a genetic and epidemiological study Annals of Human Genetics 54 1990 155 168
75. Y. Yamaguchi, M.E. Heiny, and J.D. Gitlin Isolation and characterization of a human liver Cdna as a candidate gene for Wilson disease Biochem Biophys Res Commun 197 1993 271 277
76. S.A. Pfeil, and D.J. Lynn Wilson's disease: copper unfettered J Clin Gastroenterol 29 1999 22 31
77. B. Bonne-Tamir, M. Frydman, and M.S. Agger Wilson's disease in Israel: a genetic and epidemiological study Ann Hum Genet 54 1990 155 168
78. M. Oga, N. Matsui, T. Anai, J. Yoshimatsu, I. Inoue, and I. Miyakawa Copper deposition of the fetus and placenta in a patient with untreated Wilson's disease Am J Obstet Gynecol 169 1993 196 198
79. V. Berghella, D. Steele, T. Spector, F. Cambi, and A. Johnson Successful pregnancy in a neurologically impaired woman with Wilson's disease: case report Am J Obstet Gynecol 176 1997 712 714
80. P. Dupont, O. Irion, and F. Beguin Pregnancy in a patient with treated Wilson's disease: a case report Am J Obstet Gynecol 163 1990 1527 1528
81. D. Sethi Kapil Tremor Curr Opin Neurol 16 2003 481 485
82. C.M. Tanner, and S.M. Goldman Epidemiology of movement disorders Curr Opin Neurol 7 1994 340 345
83. J.P. Hubble, K.L. Busenbark, and W.C. Koller Essential tremor Clin Neuropharmacol 12 1989 453 482
84. M.A. Leehey Tremor: diagnosis and treatment Prim Care Case Rev 4 2001 32 39
85. G.S. Connor A double blind placebo-controlled trial of topiramate treatment for essential tremor Neurology 59 2002 132 134
86. E.D. Louis Essential tremor N Engl J Med 345 2001 887 891
87. C. Palmieri, and C. Raffaele Teratogenic potential of the newer antiepileptic drugs CNS Drugs 16 2002 755 764
88. T.A. Glauser Topiramate Epilepsia 40 Suppl 5 1999 S71 S80
89. H.E. Hoyme, L. Hauck, and D. Quinn Minor anomalies accompanying prenatal exposure to topiramate [abstract] Epilepsia 56 1998 119A
90. I. Öhman, V. Sigurd, G. Luef, B. Söderfeldt, and T. Torbjörn Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations Epilepsia 43 2002 1157 1160
91. M.J. Mclean Gabapentin in the management of convulsive disorders Epilepsia 40 Suppl 6 1999 S39 S50
92. B. Bar-Oz, I. Nulman, G. Koren, and S. Ito Anticonvulsants and breast feeding: a critical review Paediatr Drugs 2 2000 113 126